1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05.24 | Cano Health, Inc.: Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan | 139 | PR Newswire | Emergence from Chapter 11 Expected in Third Quarter of 2024
MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care... ► Artikel lesen | |
| 05.02.24 | NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings | 406 | PR Newswire | MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the... ► Artikel lesen | |
| CANO HEALTH Aktie jetzt für 0€ handeln | |||||
| 05.02.24 | Cano Health, Inc.: Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position | 351 | PR Newswire | Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow
Receives Commitment for $150 Million in New Capital... ► Artikel lesen |
3 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 557,30 | -0,02 % | Opening Bell: Bitcoin, Gold, Novo Nordisk, Oracle, Meta, Alphabet, Intuitive Surgical, Boeing | Per Videoschalte umriss Donald Trump gestern beim Wirtschaftstreffen in Davos sein Wirtschaftsprogramm. Dies sorgte für gute Stimmung an der Börse. Der Dow Jones legte 0,92 Prozent zu, der Nasdaq 100... ► Artikel lesen | |
| ROKU | 81,99 | +0,04 % | Roku (NASDAQ:ROKU) Trading Up 0% - Here's What Happened | ||
| ATOSSA THERAPEUTICS | 0,827 | -0,36 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 | SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| QUIDELORTHO | 44,200 | +6,25 % | Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now | ||
| TEMPEST THERAPEUTICS | 0,915 | +1,55 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC) | BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VERU | 0,549 | -2,66 % | Veru Inc.: Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY (Semaglutide) for Weight Reduction | -- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- Patients on Enobosarm on average... ► Artikel lesen | |
| CENTENE | 62,42 | +0,56 % | Can Centene's Q4 Earnings Navigate Through Rising Medical Costs? | ||
| NANO-X IMAGING | 7,580 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| FULGENT GENETICS | 16,300 | -0,61 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| LANTHEUS | 87,34 | -2,00 % | Evergreen Theragnostics, Inc.: Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader | Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilitiesAdds OCTEVY, a registrational-stage diagnostic... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 3,540 | -3,28 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal ... | Updated interim results with an additional 10 weeks of follow-up on the nine patients in Cohorts 1 (2.5 mCi) and Cohort 2 (5.0 mCi) of the ongoing Phase 1/2a study support continuation of dose-finding... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 25,800 | -3,01 % | AMN Healthcare Services Inc. Q3 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - AMN Healthcare Services Inc. (AMN) reported earnings for third quarter that decreased from the same period last year but beat the Street estimates.The company's bottom... ► Artikel lesen | |
| OMNICELL | 43,000 | -1,38 % | Omnicell Announces Third Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen | |
| ALPHATEC | 11,500 | +3,60 % | Alphatec Holdings, Inc. Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook | CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary... ► Artikel lesen |
CANO HEALTH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,310 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANO HEALTH INC finden Sie auf Wallstreet Online.
